J.L. Molinuevo

Discipline

Psychologie (9)

Type de document

Articles (14) Recensions (2)

Co-auteur

Date

Source

Mot-clé

Alzheimer's disease (12) Amyloid (11) Biochemical markers (11) âge (9) biomarqueur (9) Human beings (9) Age (9) Age (9) pathologie (8) Weights and measures (8) Pathology (8) Dementia (8) Cognition (8) maladie (7) Apolipoprotein E (7) Cerebrospinal fluid (7) plasma (7) maladie (7) information (6) Proteins (6) Older people (6) Mild cognitive impairment (6) cohorte (6) protéine (5) Persons (5) Brain (5) Proteomics (5) cerveau (5) Diagnosis (4) Area (4)

Documents écrit par J.L. Molinuevo (14) | parle de J.L. Molinuevo (0)

Dementia prevention in memory clinics: recommendations from the European task force for brain health services.
G.B. Frisoni et al.
Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.
A. Brioschi Guevara et al. (11 oct. 2021)
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.
B.M. Tijms et al. (2 août 2021)
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
B.M. Tijms et al. (1 déc. 2020)
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset.
S. Hong et al. (22 nov. 2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
S. Westwood et al. (2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
L. Shi et al. (2020)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
L. Shi et al.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
M. Kim et al.
Inflammatory biomarkers in Alzheimer's disease plasma.
A.R. Morgan et al.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
D. Stamate et al. (2019)
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
M. Ten Kate et al. (27 sept. 2018)
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
I. Bos et al. (6 juil. 2018)
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
W.J. Jansen et al. (2015)